Persistence with oral bisphosphonates and denosumab among older adults in primary care in Ireland
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1862-3514
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Persistence with oral bisphosphonates and denosumab among older adults in primary care in Ireland ; volume:16 ; number:1 ; day:17 ; month:4 ; year:2021 ; pages:1-11 ; date:12.2021
Archives of osteoporosis ; 16, Heft 1 (17.4.2021), 1-11, 12.2021
- Creator
-
Walsh, Mary E.
Fahey, Tom
Moriarty, Frank
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11657-021-00932-7
- URN
-
urn:nbn:de:101:1-2021060511371398225009
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Walsh, Mary E.
- Fahey, Tom
- Moriarty, Frank
- SpringerLink (Online service)
Other Objects (12)
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
Medication-related osteonecrosis of the jaw : bisphosphonates, denosumab, and new agents
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab
Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis
Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France
Comparison of denosumab and oral bisphosphonates for the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Clinical efficacy of denosumab, teriparatide, and oral bisphosphonates in the prevention of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
Correction: Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Hypercalcaemia after treatment with denosumab in children: bisphosphonates as an option for therapy and prevention?
Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
Medication-related osteonecrosis of the jaw : bisphosphonates, denosumab, and new agents
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab
Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis
Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France
Comparison of denosumab and oral bisphosphonates for the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Clinical efficacy of denosumab, teriparatide, and oral bisphosphonates in the prevention of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
Correction: Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Hypercalcaemia after treatment with denosumab in children: bisphosphonates as an option for therapy and prevention?
Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
Medication-related osteonecrosis of the jaw : bisphosphonates, denosumab, and new agents
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab
Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis
Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France
Comparison of denosumab and oral bisphosphonates for the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Clinical efficacy of denosumab, teriparatide, and oral bisphosphonates in the prevention of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
Correction: Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Hypercalcaemia after treatment with denosumab in children: bisphosphonates as an option for therapy and prevention?